Clinical trial
Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary…
NCT00005997 · Case Comprehensive Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00005997 |
|---|---|
| Title | Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer |
| Official title | Phase II and Pharmacokinetic Trial of Rebeccamycin Analog in Hepatobiliary Cancers |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Liver Cancer |
| Intervention type | Drug |
| Interventions | becatecarin |
| Enrollment | 72 |
| Start date | Apr 1, 1999 |
| Primary completion | Apr 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 11, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: